Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 3
2004 3
2005 7
2006 5
2007 5
2008 5
2009 7
2010 7
2011 2
2013 1
2014 3
2015 4
2016 7
2017 5
2018 9
2019 12
2020 15
2021 13
2022 12
2023 8
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Spread through air spaces in lung neuroendocrine tumor.
Kozuma Y, Toyokawa G, Yamada Y, Shoji F, Yamazaki K, Oda Y, Takeo S. Kozuma Y, et al. Among authors: yamazaki k. Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S439-S442. doi: 10.21037/tlcr.2019.10.20. Transl Lung Cancer Res. 2019. PMID: 32038933 Free PMC article. No abstract available.
Spread through air spaces in non-small cell lung cancer.
Kozuma Y, Toyokawa G, Yamada Y, Shoji F, Yamazaki K, Oda Y, Takeo S. Kozuma Y, et al. Among authors: yamazaki k. J Thorac Dis. 2019 Sep;11(Suppl 15):S1881-S1884. doi: 10.21037/jtd.2019.08.97. J Thorac Dis. 2019. PMID: 31632774 Free PMC article. No abstract available.
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer.
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Tamiya A, et al. Among authors: yamazaki k. Lung Cancer. 2024 Sep;195:107917. doi: 10.1016/j.lungcan.2024.107917. Epub 2024 Aug 3. Lung Cancer. 2024. PMID: 39116552 Free article.
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H, Yamamoto N, Misumi T, Yoh K, Saito H, Sugawara S, Yamazaki K, Nakagawa K, Sugio K, Seto T, Toyooka S, Date H, Mitsudomi T, Okamoto I, Yokoi K, Saka H, Okamoto H, Takiguchi Y, Takahashi T, Tsuboi M. Kenmotsu H, et al. Among authors: yamazaki k. J Clin Oncol. 2023 Dec 1;41(34):5242-5246. doi: 10.1200/JCO.23.00179. Epub 2023 Sep 1. J Clin Oncol. 2023. PMID: 37656928 Clinical Trial.
A worldwide perspective on large carnivore attacks on humans.
Bombieri G, Penteriani V, Almasieh K, Ambarlı H, Ashrafzadeh MR, Das CS, Dharaiya N, Hoogesteijn R, Hoogesteijn A, Ikanda D, Jędrzejewski W, Kaboli M, Kirilyuk A, Jangid AK, Sharma RK, Kushnir H, Lamichhane BR, Mohammadi A, Monroy-Vilchis O, Mukeka JM, Nikolaev I, Ohrens O, Packer C, Pedrini P, Ratnayeke S, Seryodkin I, Sharp T, Palei HS, Smith T, Subedi A, Tortato F, Yamazaki K, Delgado MDM. Bombieri G, et al. Among authors: yamazaki k. PLoS Biol. 2023 Jan 31;21(1):e3001946. doi: 10.1371/journal.pbio.3001946. eCollection 2023 Jan. PLoS Biol. 2023. PMID: 36719873 Free PMC article.
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Taniguchi Y, et al. Among authors: yamazaki k. BMC Pulm Med. 2024 Aug 24;24(1):407. doi: 10.1186/s12890-024-03212-5. BMC Pulm Med. 2024. PMID: 39182046 Free PMC article.
138 results